Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets.Â
Global Cell Culture Media Market is valued at approximately USD 5.34 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.0% during the forecast period 2023-2030. Cell culture media, referred to as growth media, is a specialized gel or liquid designed to supply isolated cells with vital nutrients and growth factors required for their survival, division, and functioning in a controlled setting outside their natural organism. It aims to closely mimic the cells’ natural environment, allowing researchers and scientists to investigate cell behavior, formulate drugs, and even engineer tissues. The composition of cell culture media is carefully designed to provide the essential nutrients, growth factors, hormones, salts, vitamins, and other critical elements needed for the cells to survive and replicate. The media also contain serum, which is derived from animal blood and provides additional nutrients and growth factors. The global market growth is being driven by factors such as growth in stem cell research, emerging cell culture technologies for cell-based vaccines, surge in production of vaccines, increasing demand for monoclonal antibodies and biosimilars, coupled with the rising emphasis on personalized medicine.
Additionally, the expanding applications of gene therapies, especially in the treatment of neurological diseases and genetic disorders, are driving the demand for cell culture media. Researchers globally are actively engaged in discovering new therapeutic options, and gene therapy is increasingly being explored in various applications. For instance, gene therapy is utilized experimentally for treating genetic disorders such as Severe Combined Immune Deficiency (SCID), Chronic Granulomatous Disorder (CGD), and hemophilia. Gene therapy relies on viral vectors to deliver genetic sequences into target cells. OptiPEAK, a chemically defined media, is optimized for superior expansion kinetics of HEK293t, supporting clinical and commercial manufacturing in various formats. Moreover, the surge in chronic diseases especially cancer has prompted extensive research projects for advanced treatments. The use of consumables, including cell culture media, in these research initiatives is contributing to market growth by meeting the demand for essential laboratory supplies. According to the World Health Organization, in 2020, it was estimated that nearly 19.3 million new cases of cancer were recorded globally, which is projected to rise and is likely to reach 30.2 million new cases by 2040. Thus, these aforementioned factors are propelling the growth of the Cell Culture Media Market during the estimated period. Moreover, the surge in adoption of the latest cell culture technology to improve cell growth and productivity, as well as growth in stem cell research present various lucrative opportunities over the forecast years. However, the unavailability of infrastructure and ethical concerns regarding cell biology research are challenging the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Cell Culture Media Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the expansion of the biotechnology and pharmaceutical sectors, the increasing number of vaccines based on cell culture receiving approvals, the rising prevalence of illnesses such as cancer, and the growing funding and investments made in cell-based research. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing development of biopharmaceuticals, oncology, and stem cell research, as well as the surge in demand for life science research are significantly propelling the market demand across the region. Furthermore, the rise in the number of strategic activities by key industry players to expand their presence in the Asia Pacific countries is also presenting high growth prospects for market expansion. For instance, in December 2021, Fujifilm Irvine Scientific, Inc. started the construction of its new bioprocessing center in China, intending to ensure cell culture media optimization support for biotherapeutic drug development, vaccines, and advanced therapies. For instance, in December 2021, Fujifilm Irvine Scientific, Inc. announced the construction of a new bioprocessing center in China, which aims to offer comprehensive support for cell culture media optimization in the development of biotherapeutic drugs, vaccines, and advanced therapies.
Major market players included in this report are:
Thermo Fisher Scientific, Inc. (US)
Merck KGaA (Germany)
Danaher Corporation (US)
Sartorius AG (Germany)
Corning Incorporated (US)
FUJIFILM Irvine Scientific, Inc. (Japan)
Lonza Group (Switzerland)
Becton, Dickinson and Company (US)
Miltenyi Biotec (Germany)
HiMedia Laboratories Pvt. Ltd. (India)
Recent Developments in the Market:
Ø In January 2022, Cytiva and Nucleus Biologics, LLC. entered into a collaborative agreement focusing on tailored media formulation and comprehensive solutions for the gene and cell therapy sector.
Ø In September 2023, Celltrion allocated an investment of USD 94.5 million for the establishment of a facility in Songdo, Incheon, with an annual production capacity of 8 million vials. This facility is anticipated to raise the bioreactor capacity to 600,000 L and is set to become operational in 2027.
Ø In March 2023, Samsung Biologics declared its plans to initiate the construction of a fifth plant, boasting a capacity of 180,000 liters. Upon its completion, this addition is likely to solidify Samsung Biologics’ position as the leader in global biomanufacturing capacity, reaching a total of 784,000 liters.
Ø In July 2021, Sartorius AG unveiled its acquisition of Xell AG, a specialist in cell culture. Xell AG is engaged in the development, production, and marketing of media and feed supplements tailored for cell cultures in the production of viral vectors utilized in gene therapeutics and vaccines.
Ø In January 2021, Cytiva introduced the HiScreen Fibro PrismA product designed for the early stages of monoclonal antibody (mAb) purification process development. This fiber-based protein A platform expedited the company’s research and development initiatives and enhanced productivity in large-scale manufacturing environments.
Global Cell Culture Media Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Type, Application, End user, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Serum-free Media
Classical Media & Salts
Stem Cell Culture Media
Specialty Media
Chemically defined Media
Other Cell Culture Media
By Application:
Biopharmaceutical Production
Diagnostics
Drug Screening & Development
Tissue Engineering & Regenerative Medicine
Other Applications
By End user:
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Cell Culture Media Market, by Region, 2020-2030 (USD Billion)
1.2.2. Cell Culture Media Market, by Type, 2020-2030 (USD Billion)
1.2.3. Cell Culture Media Market, by Application, 2020-2030 (USD Billion)
1.2.4. Cell Culture Media Market, by End user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell Culture Media Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell Culture Media Market Dynamics
3.1. Cell Culture Media Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Surge in production of vaccines
3.1.1.2. Rising applications of gene therapies, especially in the treatment of neurological diseases and genetic disorders
3.1.2. Market Challenges
3.1.2.1. Lack of infrastructure
3.1.2.2. Ethical concerns regarding cell biology research
3.1.3. Market Opportunities
3.1.3.1. Surge in adoption of the latest cell culture technology to improve cell growth and productivity
3.1.3.2. Growth in stem cell research
Chapter 4. Global Cell Culture Media Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cell Culture Media Market, by Type
5.1. Market Snapshot
5.2. Global Cell Culture Media Market by Type, Performance – Potential Analysis
5.3. Global Cell Culture Media Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Cell Culture Media Market, Sub Segment Analysis
5.4.1. Serum-free Media
5.4.2. Classical Media & Salts
5.4.3. Stem Cell Culture Media
5.4.4. Specialty Media
5.4.5. Chemically defined Media
5.4.6. Other Cell Culture Media
Chapter 6. Global Cell Culture Media Market, by Application
6.1. Market Snapshot
6.2. Global Cell Culture Media Market by Application, Performance – Potential Analysis
6.3. Global Cell Culture Media Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Cell Culture Media Market, Sub Segment Analysis
6.4.1. Biopharmaceutical Production
6.4.2. Diagnostics
6.4.3. Drug Screening & Development
6.4.4. Tissue Engineering & Regenerative Medicine
6.4.5. Other Applications
Chapter 7. Global Cell Culture Media Market, by End user
7.1. Market Snapshot
7.2. Global Cell Culture Media Market by End user, Performance – Potential Analysis
7.3. Global Cell Culture Media Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
7.4. Cell Culture Media Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Hospitals & Diagnostic Laboratories
7.4.3. Research & Academic Institutes
7.4.4. Other End Users
Chapter 8. Global Cell Culture Media Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Cell Culture Media Market, Regional Market Snapshot
8.4. North America Cell Culture Media Market
8.4.1. U.S. Cell Culture Media Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End user breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Cell Culture Media Market
8.5. Europe Cell Culture Media Market Snapshot
8.5.1. U.K. Cell Culture Media Market
8.5.2. Germany Cell Culture Media Market
8.5.3. France Cell Culture Media Market
8.5.4. Spain Cell Culture Media Market
8.5.5. Italy Cell Culture Media Market
8.5.6. Rest of Europe Cell Culture Media Market
8.6. Asia-Pacific Cell Culture Media Market Snapshot
8.6.1. China Cell Culture Media Market
8.6.2. India Cell Culture Media Market
8.6.3. Japan Cell Culture Media Market
8.6.4. Australia Cell Culture Media Market
8.6.5. South Korea Cell Culture Media Market
8.6.6. Rest of Asia Pacific Cell Culture Media Market
8.7. Latin America Cell Culture Media Market Snapshot
8.7.1. Brazil Cell Culture Media Market
8.7.2. Mexico Cell Culture Media Market
8.8. Middle East & Africa Cell Culture Media Market
8.8.1. Saudi Arabia Cell Culture Media Market
8.8.2. South Africa Cell Culture Media Market
8.8.3. Rest of Middle East & Africa Cell Culture Media Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Thermo Fisher Scientific, Inc. (US)
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Merck KGaA (Germany)
9.3.3. Danaher Corporation (US)
9.3.4. Sartorius AG (Germany)
9.3.5. Corning Incorporated (US)
9.3.6. FUJIFILM Irvine Scientific, Inc. (Japan)
9.3.7. Lonza Group (Switzerland)
9.3.8. Becton, Dickinson and Company (US)
9.3.9. Miltenyi Biotec (Germany)
9.3.10. HiMedia Laboratories Pvt. Ltd. (India)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.
Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.
24x7 Chat Support plus
free analyst hours with every purchase
Our 360-degree approach of market study, our research methods leave stones unturned.
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We offer wide range of services including Syndicated Reports, Customized Reports, Competitive Intelligence and others.
